These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 33174652)
1. Effects of dexamethasone and gamma globulin combined with prednisone on the therapeutic effect and immune function of Henoch-Schonlein purpura nephritis in children. Chen L; Wang X; Yin L; Ma K; Liu X J Clin Lab Anal; 2021 Jan; 35(1):e23580. PubMed ID: 33174652 [TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children. Fu H; Mao J; Xu Y; Gu W; Zhu X; Liu A Clinics (Sao Paulo); 2016 Sep; 71(9):550-4. PubMed ID: 27652838 [TBL] [Abstract][Full Text] [Related]
3. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity. Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis. Lu Z; Song J; Mao J; Xia Y; Wang C Med Sci Monit; 2017 May; 23():2333-2339. PubMed ID: 28515415 [TBL] [Abstract][Full Text] [Related]
5. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites. Yu M; Song X; Guo J; Feng Q; Tian J Eur J Pediatr; 2024 Jul; 183(7):3117-3128. PubMed ID: 38668796 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb. Xia Y; Mao J; Chen Y; Wang D; Cao L; Yao S; Fu H; Du L; Liu A Pediatr Nephrol; 2011 Jul; 26(7):1083-8. PubMed ID: 21387156 [TBL] [Abstract][Full Text] [Related]
7. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports. Cho S; Jang S; Ryu SS; Park S Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432 [TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial. Ding Y; Zhang X; Ren X; Zhai W; He L; Liu J; Yao C; Han S; Wang L Trials; 2019 Aug; 20(1):538. PubMed ID: 31464626 [TBL] [Abstract][Full Text] [Related]
9. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Jelusic M; Sestan M; Cimaz R; Ozen S Pediatr Rheumatol Online J; 2019 Feb; 17(1):10. PubMed ID: 30819179 [TBL] [Abstract][Full Text] [Related]
10. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children. Zhu Y; Dong Y; Wu L; Deng F BMC Pediatr; 2019 Nov; 19(1):409. PubMed ID: 31684904 [TBL] [Abstract][Full Text] [Related]
11. Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials. Xue X; Liu XH; Lu CL; Jin XY; Liu Q; Wang XQ; Liu JP BMC Complement Med Ther; 2021 Nov; 21(1):278. PubMed ID: 34743723 [TBL] [Abstract][Full Text] [Related]
12. Changes of Peripheral Blood Lymphocyte Subsets and Immune Function in Children with Henoch-Schonlein Purpura Nephritis. Su Q; Jiang L; Chai J; Dou Z; Rong Z; Zhao X; Yu B; Wang Y; Wang X Iran J Immunol; 2021 Sep; 18(3):259-267. PubMed ID: 34596591 [TBL] [Abstract][Full Text] [Related]
13. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center. Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis]. Ru L; Abudouhaer A; Guo YF Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600 [TBL] [Abstract][Full Text] [Related]
15. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children. Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721 [TBL] [Abstract][Full Text] [Related]
16. Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis. Wang J; Ying Q; Zhong S; Chen Y; Di Y; Dai X; Zheng J; Shen M Pediatr Neonatol; 2018 Jun; 59(3):238-243. PubMed ID: 28919104 [TBL] [Abstract][Full Text] [Related]
17. Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice. Jiang MY; Li W; Xu XP; Zhou JQ; Jiang H Chin Med J (Engl); 2019 Aug; 132(16):1942-1950. PubMed ID: 31365430 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of mycophenolate mofetil or cyclophosphamide in children with Henoch-Schönlein purpura nephritis of different age groups]. DU PW; Wen YB; Chen CY; Tu J; Li HR Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1113-1117. PubMed ID: 37990454 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents. Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study. Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]